Gossamer Bio

Gossamer Bio

gossamerbio.com

Gossamer Bio is a clinical‑stage biopharmaceutical company focused on developing precision therapies for pulmonary, immuno‑inflammatory and related diseases. Its lead program, seralutinib, is an inhaled PDGFRα/β, CSF1R and c‑KIT inhibitor formulated for delivery via dry powder inhaler for potential treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH‑ILD). The company emphasizes targeted, inhaled and systemic approaches designed to maximize local lung exposure while minimizing systemic side effects, advancing candidates through clinical development and strategic partnerships.

ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

© All Rights Reserved. ApplyBlast.com